echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > The world's first new crown DNA vaccine approved: 67% effective against Delta strain

    The world's first new crown DNA vaccine approved: 67% effective against Delta strain

    • Last Update: 2021-10-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Article source: Medical Rubik's Cube Pro

    Author: Haimer

    According to a report by Nature on September 2, the Indian drug regulatory agency approved the world's first DNA vaccine ZyCoV-D to prevent new crown infections in people 12 years and older
    .
    In a large-scale clinical trial involving 28,000 people, the vaccine has an effective rate of 67%

    .

    ZyCoV-D was developed by the Indian pharmaceutical company Zydus Cadila and does not require injection
    .
    The needle-free device pressed on the skin uses a small flow of high-pressure liquid to pierce the skin, making it less painful than injection

    .

    DNA vaccines contain circular DNA that encodes antigenic information, which is commonly referred to as a "plasmid
    .
    " After the plasmid enters the human nucleus, it is transcribed into mRNA and then translated into antigen protein in the cytoplasm

    .
    Like most new coronavirus vaccines, the target protein of this DNA vaccine is also the S protein on the surface of SARS-CoV-2

    .
    After the plasmid enters the human body, it will be degraded in the next few weeks or months

    .

    In contrast to mRNAs that do not need to enter the nucleus and can be directly translated into antigenic proteins in the cytoplasm, the challenge of DNA vaccines lies in the first step of transcription
    .
    In previous clinical trials, DNA vaccines were difficult to induce a strong immune response in the body, so they were only used in veterinary vaccines

    .
    This approval heralds the first large-scale use of DNA vaccines in humans

    .

    DNA vaccines also have their unique advantages
    .
    Compared with mRNA vaccines, DNA vaccines have greatly improved stability and are easier to mass produce

    .
    Ai Di Weixin, a leading domestic DNA vaccine company, revealed in an earlier interview that DNA vaccines can be stored at room temperature

    .

    Regarding the vaccine effectiveness 67% lower than the mRNA vaccine, the researchers said that the two are not comparable
    .
    When the effectiveness test of the DNA vaccine was carried out at the beginning of this year, the epidemic strain was already a variant of Delta

    .

    Unlike mRNA vaccines that use lipid nanoparticles (LNP) for in vivo delivery, DNA vaccines are usually delivered using electroporation devices
    .
    Under the action of the electric field, human cells instantly open the cell pores, and the plasmid enters the cells efficiently through the pores; as soon as the electric field disappears, the cell pores will be closed and restored immediately

    .

    Zydus Cadila said that the vaccine will be vaccinated in India in September this year, and it is expected to achieve a production capacity of 50 million doses early next year
    .
    At present, Zydus Cadila has not announced the results of the later clinical trials of the vaccine, and some researchers have expressed doubts about it

    .
    The company said that the data is being sorted out and will be fully disclosed to the public soon

    .

    In addition, the vaccine requires at least 3 injections to protect it
    .
    During the COVID-19 pandemic, it has brought no small logistical challenges

    .

    Domestically, Ai Di Weixin has stated that the new crown DNA vaccine cooperating with Inovio will complete phase III clinical trials within this year and is expected to be approved for marketing in the second half of the year
    .

    Note: The original text has been deleted

    Reference materials:

    [1] Smriti Mallapaty, India's DNA COVID vaccine is a world first – more are coming.
    Nature.
    (2021).

    [2] Ai Di Weixin founding scientist Wang Bin: Prepare for thirty years, the DNA vaccine is ready (Source: Medical Rubik's Cube)

    [3] Interview | The world's first new crown DNA vaccine is expected to be available within this year, and Ai Di Weixin RSV vaccine will enter clinical phase II (Source: DeepTech)

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.